Registered entities
GRACELL BIOPHARMACEUTICALS, INC.
Reg. No. 844826800United States
Social engagement
Social engagement: 5.5K social following, 5 posts in the last 12 months — top quartile of its industry.
Investor mix
16 investors on record; lead investors include Lilly Asia Ventures, 6 Dimensions Capital, Temasek, Kingdon Capital Management; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 44% |
| Private equity | 1 | 6% |
| Angel & family office | 1 | 6% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 6 | 38% |
Recent activity
10 Dec 2025
Milestone
regulatory